...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Reports of Exempt Distribution

"Its absolutely amazing how both companies,,the sister one included can not capitalize on anything positive around them or invloved with them,,,,,..good news or sector interest all seems to be a hindrance and a mute influence on our value,,!!"

narmac, the fact that Zenith only trades on the OTC market has done a great injustice to its shareholders.

Investopedia: "The primary risks involved in trading over-the-counter (OTC) stocks are two-fold. One, there is usually a lack of reliable information about the company. Two, OTC shares are commonly exchanged in thinly traded markets."

This dampens the realistic value of the stock when it makes it difficult for investors to determine the real potential of the stock due to a lack of information about the company, outside the people that are already invested in it.  

 

Koo

 

 

Share
New Message
Please login to post a reply